Inflammatory biomarker profiles of mental disorders and their relation to clinical, social and lifestyle factors (Q38208771)

31 August 2017

Inflammatory biomarker profiles of mental disorders and their relation to clinical, social and lifestyle factors (English)

1 reference

31 August 2017

0 references

0 references

Alice Russell

2

0 references

Carmine Pariante

object named as

Carmine M Pariante

series ordinal

3

0 references

author name string

David Baumeister

series ordinal

1

1 reference

PubMed ID

24789456

31 August 2017

Valeria Mondelli

series ordinal

4

1 reference

31 August 2017

1 May 2014

1 reference

Social Psychiatry and Psychiatric Epidemiology

31 August 2017

1 reference

31 August 2017

49

1 reference

31 August 2017

6

1 reference

31 August 2017

841-849

1 reference

From inflammation to sickness and depression: when the immune system subjugates the brain

31 August 2017

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Neuropsychiatric adverse effects of interferon-alpha: recognition and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Do corticosteroids damage the brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

The glucocorticoid receptor: part of the solution or part of the problem?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

The HPA axis in major depression: classical theories and new developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

A systematic review of the activity of the hypothalamic-pituitary-adrenal axis in first episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Abnormal cortisol levels during the day and cortisol awakening response in first-episode psychosis: the role of stress and of antipsychotic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Biological indicators of illness risk in offspring of bipolar parents: targeting the hypothalamic-pituitary-adrenal axis and immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Glucocorticoid receptor dimerization is required for proper recovery of LPS-induced inflammation, sickness behavior and metabolism in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Interferon-alpha-induced serotonin uptake in Jurkat T cells via mitogen-activated protein kinase and transcriptional regulation of the serotonin transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

p38 MAPK activation elevates serotonin transport activity via a trafficking-independent, protein phosphatase 2A-dependent process

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Interleukin-1 receptor activation by systemic lipopolysaccharide induces behavioral despair linked to MAPK regulation of CNS serotonin transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Glucocorticoids, cytokines and brain abnormalities in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Interleukin-1β: a new regulator of the kynurenine pathway affecting human hippocampal neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Oxidative stress in schizophrenia: an integrated approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

The molecular neurobiology of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Reactive nitrogen species in the chemical biology of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Insulin-like growth factor-1 abrogates microglial oxidative stress and TNF-α responses to spreading depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Association between serum brain-derived neurotrophic factor and plasma interleukin-6 in major depressive disorder with melancholic features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Tumor necrosis factor-alpha and interleukin-6 regulate secretion of brain-derived neurotrophic factor in human monocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Stress and inflammation reduce brain-derived neurotrophic factor expression in first-episode psychosis: a pathway to smaller hippocampal volume

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

A meta-analysis of cytokines in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

A meta-analysis of differences in IL-6 and IL-10 between people with and without depression: exploring the causes of heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Penetration of interleukin-6 across the murine blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Soluble IL-2Rα facilitates IL-2-mediated immune responses and predicts reduced survival in follicular B-cell non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

C-reactive protein: how conformational changes influence inflammatory properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

The IL-6/sIL-6R complex as a novel target for therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

The role of inflammatory cytokines in suicidal behavior: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Interleukin-6, C-reactive protein and interleukin-10 after antidepressant treatment in people with depression: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Inflammatory markers in antipsychotic-naïve patients with nonaffective psychosis and deficit vs. nondeficit features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Elevated C-reactive protein and cognitive deficits in individuals with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Childhood maltreatment predicts adult inflammation in a life-course study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Childhood maltreatment and inflammatory markers: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Low early-life social class leaves a biological residue manifested by decreased glucocorticoid and increased proinflammatory signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Maternal warmth buffers the effects of low early-life socioeconomic status on pro-inflammatory signaling in adulthood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Cytokines sing the blues: inflammation and the pathogenesis of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Reduced cingulate gyrus volume associated with enhanced cortisol awakening response in young healthy adults reporting childhood trauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Acculturation, childhood trauma and the cortisol awakening response in Mexican-American adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Dex/CRH test cortisol response in outpatients with major depression and matched healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Neurobiology of early life stress: clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Synergistic childhood adversities and complex adult psychopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Childhood adversities increase the risk of psychosis: a meta-analysis of patient-control, prospective- and cross-sectional cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Psychiatric and physical sequelae of childhood physical and sexual abuse and forced sexual trauma among individuals with serious mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

The effects of acute psychological stress on circulating inflammatory factors in humans: a review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Emotional reactivity to daily events in major and minor depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Clinical depression and regulation of the inflammatory response during acute stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Differential neuroendocrine and immune responses to acute psychosocial stress in women with type 1 bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Association between plasma IL-6 response to acute stress and early-life adversity in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

So depression is an inflammatory disease, but where does the inflammation come from?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Schizophrenia in patients with atopic disorders with particular emphasis on asthma: a Danish population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Gene, gut and schizophrenia: the meeting point for the gene-environment interaction in developing schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

To assess, to control, to exclude: effects of biobehavioral factors on circulating inflammatory markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Inflammation and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Immunity, inflammation, and bipolar disorder: diagnostic and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00127-014-0887-Z

Cytokine production and treatment response in major depressive disorder

21 January 2018

1 reference

12 December 2020

The dexamethasone/corticotropin-releasing factor test in men with major depression: role of childhood trauma

1 reference

12 December 2020

Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment

1 reference

12 December 2020

Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress

1 reference

12 December 2020

Effects of symptomatic severity on elevation of plasma soluble interleukin-2 receptor in bipolar mania

1 reference

12 December 2020

The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters

1 reference

12 December 2020

Behavioural sensitization to daily life stress in psychosis

1 reference

12 December 2020

Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression

1 reference

12 December 2020

Activation of indices of cell-mediated immunity in bipolar mania

1 reference

12 December 2020

An assessment of periodontal health in patients with schizophrenia and taking antipsychotic medication

1 reference

12 December 2020

Cytokines in bipolar disorder: a systematic review and meta-analysis

1 reference

12 December 2020

C-reactive protein is associated with the severity of cognitive impairment but not of psychiatric symptoms in individuals with schizophrenia

1 reference

12 December 2020

Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies

1 reference

12 December 2020

10.1007/S00127-014-0887-Z

Identifiers

DOI

1 reference

31 August 2017

1 reference

PubMed ID

24789456